Michael Peregrine and Stephen Wu author an article in the American Health Law Association‘s Health Law Weekly. in this article, they analyze the impact of a statement made by the Federal Trade Commission to revitalize its interpretation of the Commission’s authority to challenge “unfair methods of competition” beyond those prohibited by the Sherman and Clayton Acts.

To read the first part, click here.